Literature DB >> 19885726

Recombinant dengue virus-like particles from Pichia pastoris: efficient production and immunological properties.

Wenquan Liu1, Hanning Jiang, Junmei Zhou, Xiaomeng Yang, Yunxia Tang, Danyun Fang, Lifang Jiang.   

Abstract

The envelope glycoprotein (E) of flavivirus is the major structural protein on the surface of the mature virions. The complexes of premembrane (prM) and E play important roles in virus assembly and fusion modulation and in potential immunity-inducing vaccines. In the present study, the cDNA encoding prM and E proteins of dengue virus type 2 (DENV-2) was subcloned into the pGAPZalphaA vector and further integrated into the genome of Pichia pastoris under the control of the glyceraldehyde-3-phosphate dehydrogenase (GAP) constitutive promoter. The high-level constitutive expression of recombinant E antigen was achieved in P. pastoris. Both the cell lysate and the culture supernatant, examined by electron microscopy, were found to contain DENV-2 virus-like particles (VLPs) with diameters of about 30 nm. After immunization of BALB/c mice, the VLPs exhibited similar efficacies as inactivated virus in terms of antibody induction and neutralization titer. These results suggest that recombinant DENV VLPs can be efficiently produced in the GAP promoter-based P. pastoris expression system. This system may be useful for the development of effective and economic dengue subunit vaccine.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19885726     DOI: 10.1007/s11262-009-0418-2

Source DB:  PubMed          Journal:  Virus Genes        ISSN: 0920-8569            Impact factor:   2.332


  30 in total

1.  Particulate vaccine candidate for Japanese encephalitis induces long-lasting virus-specific memory T lymphocytes in mice.

Authors:  E Konishi; K S Win; I Kurane; P W Mason; R E Shope; F A Ennis
Journal:  Vaccine       Date:  1997-02       Impact factor: 3.641

2.  Two distinct size classes of immature and mature subviral particles from tick-borne encephalitis virus.

Authors:  Steven L Allison; Yizhi J Tao; Gabriel O'Riordain; Christian W Mandl; Stephen C Harrison; Franz X Heinz
Journal:  J Virol       Date:  2003-11       Impact factor: 5.103

Review 3.  Dengue.

Authors:  Scott B Halstead
Journal:  Lancet       Date:  2007-11-10       Impact factor: 79.321

Review 4.  Prospects for a dengue virus vaccine.

Authors:  Stephen S Whitehead; Joseph E Blaney; Anna P Durbin; Brian R Murphy
Journal:  Nat Rev Microbiol       Date:  2007-07       Impact factor: 60.633

5.  Expression of the dengue virus structural proteins in Pichia pastoris leads to the generation of virus-like particles.

Authors:  R J Sugrue; J Fu; J Howe; Y C Chan
Journal:  J Gen Virol       Date:  1997-08       Impact factor: 3.891

6.  Generation and characterization of a mammalian cell line continuously expressing Japanese encephalitis virus subviral particles.

Authors:  E Konishi; A Fujii; P W Mason
Journal:  J Virol       Date:  2001-03       Impact factor: 5.103

7.  Recombinant vaccinia viruses co-expressing dengue-1 glycoproteins prM and E induce neutralizing antibodies in mice.

Authors:  B A Fonseca; S Pincus; R E Shope; E Paoletti; P W Mason
Journal:  Vaccine       Date:  1994       Impact factor: 3.641

8.  Structure of the dengue virus envelope protein after membrane fusion.

Authors:  Yorgo Modis; Steven Ogata; David Clements; Stephen C Harrison
Journal:  Nature       Date:  2004-01-22       Impact factor: 49.962

9.  Blocking the dengue virus 2 infections on BHK-21 cells with purified recombinant dengue virus 2 E protein expressed in Escherichia coli.

Authors:  Mei-Wui Chiu; Yun-Liang Yang
Journal:  Biochem Biophys Res Commun       Date:  2003-09-26       Impact factor: 3.575

10.  Expression of SARS-coronavirus spike glycoprotein in Pichia pastoris.

Authors:  Chi-Pang Chuck; Chi-Hang Wong; Larry Ming-Cheung Chow; Kwok-Pui Fung; Mary Miu-Yee Waye; Stephen Kwok-Wing Tsui
Journal:  Virus Genes       Date:  2008-10-29       Impact factor: 2.332

View more
  20 in total

1.  An alphavirus vector-based tetravalent dengue vaccine induces a rapid and protective immune response in macaques that differs qualitatively from immunity induced by live virus infection.

Authors:  Laura J White; Carlos A Sariol; Melissa D Mattocks; Wahala Wahala M P B; Vorraphun Yingsiwaphat; Martha L Collier; Jill Whitley; Rochelle Mikkelsen; Idia V Rodriguez; Melween I Martinez; Aravinda de Silva; Robert E Johnston
Journal:  J Virol       Date:  2013-01-09       Impact factor: 5.103

Review 2.  The development of recombinant subunit envelope-based vaccines to protect against dengue virus induced disease.

Authors:  Beth-Ann G Coller; David E Clements; Andrew J Bett; Sangeetha L Sagar; Jan H Ter Meulen
Journal:  Vaccine       Date:  2011-07-21       Impact factor: 3.641

3.  Expression of dengue-3 premembrane and envelope polyprotein in lettuce chloroplasts.

Authors:  Anderson Paul Kanagaraj; Dheeraj Verma; Henry Daniell
Journal:  Plant Mol Biol       Date:  2011-03-24       Impact factor: 4.076

4.  Evaluation of extracellular subviral particles of dengue virus type 2 and Japanese encephalitis virus produced by Spodoptera frugiperda cells for use as vaccine and diagnostic antigens.

Authors:  Miwa Kuwahara; Eiji Konishi
Journal:  Clin Vaccine Immunol       Date:  2010-07-28

5.  Recombinant Dengue Virus 4 Envelope Glycoprotein Virus-Like Particles Derived from Pichia pastoris are Capable of Eliciting Homotypic Domain III-Directed Neutralizing Antibodies.

Authors:  Niyati Khetarpal; Rahul Shukla; Ravi Kant Rajpoot; Ankur Poddar; Meena Pal; Sathyamangalam Swaminathan; Upasana Arora; Navin Khanna
Journal:  Am J Trop Med Hyg       Date:  2016-11-07       Impact factor: 2.345

6.  Cloning and Expression of Recombinant Tick-Borne Encephalitis Virus-like Particles in Pichia pastoris.

Authors:  Seok-Min Yun; Young Eui Jeong; Eunbyeol Wang; Ye-Ji Lee; Myung Guk Han; Chan Park; Won-Ja Lee; WooYoung Choi
Journal:  Osong Public Health Res Perspect       Date:  2014-09-04

7.  Tetravalent recombinant dengue virus-like particles as potential vaccine candidates: immunological properties.

Authors:  Yan Liu; Junmei Zhou; Zhizhun Yu; Danyun Fang; Chunyun Fu; Xun Zhu; Zhenjian He; Huijun Yan; Lifang Jiang
Journal:  BMC Microbiol       Date:  2014-12-18       Impact factor: 3.605

8.  Pichia pastoris-expressed dengue 2 envelope forms virus-like particles without pre-membrane protein and induces high titer neutralizing antibodies.

Authors:  Shailendra Mani; Lav Tripathi; Rajendra Raut; Poornima Tyagi; Upasana Arora; Tarani Barman; Ruchi Sood; Alka Galav; Wahala Wahala; Aravinda de Silva; Sathyamangalam Swaminathan; Navin Khanna
Journal:  PLoS One       Date:  2013-05-23       Impact factor: 3.240

9.  Pichia pastoris-expressed dengue 3 envelope-based virus-like particles elicit predominantly domain III-focused high titer neutralizing antibodies.

Authors:  Lav Tripathi; Shailendra Mani; Rajendra Raut; Ankur Poddar; Poornima Tyagi; Upasana Arora; Aravinda de Silva; Sathyamangalam Swaminathan; Navin Khanna
Journal:  Front Microbiol       Date:  2015-09-23       Impact factor: 5.640

10.  Recognition of heparan sulfate by clinical strains of dengue virus serotype 1 using recombinant subviral particles.

Authors:  Charlermchai Artpradit; Luke N Robinson; Boris K Gavrilov; Troy T Rurak; Mathuros Ruchirawat; Ram Sasisekharan
Journal:  Virus Res       Date:  2013-05-22       Impact factor: 3.303

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.